APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artificial Blood Substitute

Artificial blood refers to artificial blood cells and their functional substitutes. Its function, as the name suggests, is to replace real human blood to meet people's demand for blood and make up for the current blood shortage.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Artificial blood refers to artificial blood cells and their functional substitutes. Its function, as the name suggests, is to replace real human blood to meet people's demand for blood and make up for the current blood shortage.

Selected research

Market Structure

Global Artificial Blood Substitute Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025188 pages

Choose your research edition.

Industry ResearchArtificial Blood Substitute Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Blood Substitute Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Artificial Blood Substitute Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Blood Substitute Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Blood Substitute Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Artificial blood refers to artificial blood cells and their functional substitutes. Its function, as the name suggests, is to replace real human blood to meet people's demand for blood and make up for the current blood shortage.

Artificial blood substitutes are used as oxygen therapy agents for emergency resuscitation and disease treatment. They have very important practical significance in developing countries and field hospitals that lack blood and urgently need blood transfusion, lack refrigeration equipment, and even on the battlefield. At the same time they do have great potential in reducing the spread of infectious diseases and providing new options for religious people who refuse blood transfusions.

Despite the huge application prospects, these artificial blood products all face some common problems. In addition to the safety and efficacy to be verified by clinical trials, the current production scale still needs to be greatly increased, and the production cost needs to be greatly reduced to meet the future demand for artificial blood .

Read the full market overview

Report Includes

This report provides an overview of the global Artificial Blood Substitute market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Artificial Blood Substitute and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Artificial Blood Substitute revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Artificial Blood Substitute market size, projected growth trends, production technologies, key applications, and end-use industries.

Artificial Blood Substitute Segment by Company

Aurum Biosciences Ltd.

HEMARINA SA

HbO2 Therapeutics

KaloCyte Inc.

SpheriTech Ltd.

NuvOx Pharma

Artificial Blood Substitute Segment by Type

Perfluorocarbon-based Oxygen Carrier (PFBOC)

Hemoglobin-based Oxygen Carrier (HBOC)

Artificial Blood Substitute Segment by Application

Military

Civil

Artificial Blood Substitute Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Blood Substitute market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Blood Substitute and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Blood Substitute.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Artificial Blood Substitute in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artificial Blood Substitute industry.

Chapter 3: Detailed analysis of Artificial Blood Substitute companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Blood Substituterevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Artificial Blood Substitute Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Perfluorocarbon-based Oxygen Carrier (PFBOC) Table 3. Key Players of Hemoglobin-based Oxygen Carrier (HBOC) Table 4. Global Artificial Blood Substitute Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Military Table 6. Key Players of Civil Table 7. Global Artificial Blood Substitute Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Artificial Blood Substitute Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Artificial Blood Substitute Market Share by Region (2021-2026) Table 10. Global Artificial Blood Substitute Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Artificial Blood Substitute Market Share by Region (2027-2032) Table 12. Artificial Blood Substitute Industry Trends Table 13. Artificial Blood Substitute Industry Drivers Table 14. Artificial Blood Substitute Industry Opportunities and Challenges Table 15. Artificial Blood Substitute Industry Restraints Table 16. Global Artificial Blood Substitute Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Artificial Blood Substitute Revenue Market Share by Company (2021-2026) Table 18. Global Artificial Blood Substitute Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Artificial Blood Substitute Key Company Head Office and Area Served Table 20. Global Artificial Blood Substitute Company, Product Type & Application Table 21. Global Artificial Blood Substitute Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Artificial Blood Substitute by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Artificial Blood Substitute Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Artificial Blood Substitute Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Artificial Blood Substitute Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Artificial Blood Substitute Revenue Market Share by Type (2021-2026) Table 28. Global Artificial Blood Substitute Revenue Market Share by Type (2027-2032) Table 29. Global Artificial Blood Substitute Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Artificial Blood Substitute Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Artificial Blood Substitute Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Artificial Blood Substitute Revenue Market Share by Application (2021-2026) Table 33. Global Artificial Blood Substitute Revenue Market Share by Application (2027-2032) Table 34. Aurum Biosciences Ltd. Company Information Table 35. Aurum Biosciences Ltd. Business Overview Table 36. Aurum Biosciences Ltd. Artificial Blood Substitute Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Aurum Biosciences Ltd. Artificial Blood Substitute Product Portfolio Table 38. Aurum Biosciences Ltd. Recent Development Table 39. HEMARINA SA Company Information Table 40. HEMARINA SA Business Overview Table 41. HEMARINA SA Artificial Blood Substitute Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. HEMARINA SA Artificial Blood Substitute Product Portfolio Table 43. HEMARINA SA Recent Development Table 44. HbO2 Therapeutics Company Information Table 45. HbO2 Therapeutics Business Overview Table 46. HbO2 Therapeutics Artificial Blood Substitute Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. HbO2 Therapeutics Artificial Blood Substitute Product Portfolio Table 48. HbO2 Therapeutics Recent Development Table 49. KaloCyte Inc. Company Information Table 50. KaloCyte Inc. Business Overview Table 51. KaloCyte Inc. Artificial Blood Substitute Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. KaloCyte Inc. Artificial Blood Substitute Product Portfolio Table 53. KaloCyte Inc. Recent Development Table 54. SpheriTech Ltd. Company Information Table 55. SpheriTech Ltd. Business Overview Table 56. SpheriTech Ltd. Artificial Blood Substitute Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. SpheriTech Ltd. Artificial Blood Substitute Product Portfolio Table 58. SpheriTech Ltd. Recent Development Table 59. NuvOx Pharma Company Information Table 60. NuvOx Pharma Business Overview Table 61. NuvOx Pharma Artificial Blood Substitute Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. NuvOx Pharma Artificial Blood Substitute Product Portfolio Table 63. NuvOx Pharma Recent Development Table 64. North America Artificial Blood Substitute Market Size by Type (2021-2026) & (US$ Million) Table 65. North America Artificial Blood Substitute Market Size by Type (2027-2032) & (US$ Million) Table 66. North America Artificial Blood Substitute Market Size by Application (2021-2026) & (US$ Million) Table 67. North America Artificial Blood Substitute Market Size by Application (2027-2032) & (US$ Million) Table 68. North America Artificial Blood Substitute Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 69. North America Artificial Blood Substitute Market Size by Country (2021-2026) Table 70. North America Artificial Blood Substitute Market Size by Country (2027-2032) Table 71. Europe Artificial Blood Substitute Market Size by Type (2021-2026) & (US$ Million) Table 72. Europe Artificial Blood Substitute Market Size by Type (2027-2032) & (US$ Million) Table 73. Europe Artificial Blood Substitute Market Size by Application (2021-2026) & (US$ Million) Table 74. Europe Artificial Blood Substitute Market Size by Application (2027-2032) & (US$ Million) Table 75. Europe Artificial Blood Substitute Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. Europe Artificial Blood Substitute Market Size by Country (2021-2026) Table 77. Europe Artificial Blood Substitute Market Size by Country (2027-2032) Table 78. China Artificial Blood Substitute Market Size by Type (2021-2026) & (US$ Million) Table 79. China Artificial Blood Substitute Market Size by Type (2027-2032) & (US$ Million) Table 80. China Artificial Blood Substitute Market Size by Application (2021-2026) & (US$ Million) Table 81. China Artificial Blood Substitute Market Size by Application (2027-2032) & (US$ Million) Table 82. Asia Artificial Blood Substitute Market Size by Type (2021-2026) & (US$ Million) Table 83. Asia Artificial Blood Substitute Market Size by Type (2027-2032) & (US$ Million) Table 84. Asia Artificial Blood Substitute Market Size by Application (2021-2026) & (US$ Million) Table 85. Asia Artificial Blood Substitute Market Size by Application (2027-2032) & (US$ Million) Table 86. Asia Artificial Blood Substitute Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Asia Artificial Blood Substitute Market Size by Country (2021-2026) Table 88. Asia Artificial Blood Substitute Market Size by Country (2027-2032) Table 89. South America, Middle East & Africa Artificial Blood Substitute Market Size by Type (2021-2026) & (US$ Million) Table 90. South America, Middle East & Africa Artificial Blood Substitute Market Size by Type (2027-2032) & (US$ Million) Table 91. South America, Middle East & Africa Artificial Blood Substitute Market Size by Application (2021-2026) & (US$ Million) Table 92. South America, Middle East & Africa Artificial Blood Substitute Market Size by Application (2027-2032) & (US$ Million) Table 93. South America, Middle East & Africa Artificial Blood Substitute Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. South America, Middle East & Africa Artificial Blood Substitute Market Size by Country (2021-2026) Table 95. South America, Middle East & Africa Artificial Blood Substitute Market Size by Country (2027-2032) Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Artificial Blood Substitute Product Image Figure 2. Global Artificial Blood Substitute Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Artificial Blood Substitute Market Share by Type: 2025 VS 2032 Figure 4. Perfluorocarbon-based Oxygen Carrier (PFBOC) Image Figure 5. Hemoglobin-based Oxygen Carrier (HBOC) Image Figure 6. Global Artificial Blood Substitute Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Artificial Blood Substitute Market Share by Application: 2025 VS 2032 Figure 8. Military Image Figure 9. Civil Image Figure 10. Global Artificial Blood Substitute Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 12. Global Artificial Blood Substitute Market Share by Region: 2025 VS 2032 Figure 13. Years Considered Figure 14. Global Artificial Blood Substitute Market Share by Players in 2025 Figure 15. Global Top 5 and 10 Artificial Blood Substitute Players Market Share by Revenue in 2025 Figure 16. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Artificial Blood Substitute Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Artificial Blood Substitute Revenue Market Share by Type (2021-2032) Figure 19. Global Artificial Blood Substitute Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Artificial Blood Substitute Revenue Market Share by Application (2021-2032) Figure 21. North America Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 22. North America Artificial Blood Substitute Market Share by Type (2021-2032) Figure 23. North America Artificial Blood Substitute Market Share by Application (2021-2032) Figure 24. North America Artificial Blood Substitute Market Share by Country (2021-2032) Figure 25. United States Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 26. Canada Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 27. Mexico Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 28. Europe Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 29. Europe Artificial Blood Substitute Market Share by Type (2021-2032) Figure 30. Europe Artificial Blood Substitute Market Share by Application (2021-2032) Figure 31. Europe Artificial Blood Substitute Market Share by Country (2021-2032) Figure 32. Germany Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 33. France Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 34. U.K. Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 35. Italy Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 36. Russia Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 37. Nordic Countries Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 38. China Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 39. China Artificial Blood Substitute Market Share by Type (2021-2032) Figure 40. China Artificial Blood Substitute Market Share by Application (2021-2032) Figure 41. Asia Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 42. Asia Artificial Blood Substitute Market Share by Type (2021-2032) Figure 43. Asia Artificial Blood Substitute Market Share by Application (2021-2032) Figure 44. Asia Artificial Blood Substitute Market Share by Country (2021-2032) Figure 45. Japan Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 46. South Korea Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 47. Taiwan Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 48. Southeast Asia Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 49. India Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 50. Australia Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 51. South America, Middle East & Africa Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Artificial Blood Substitute Market Share by Type (2021-2032) Figure 53. South America, Middle East & Africa Artificial Blood Substitute Market Share by Application (2021-2032) Figure 54. South America, Middle East & Africa Artificial Blood Substitute Market Share by Country (2021-2032) Figure 55. Brazil Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 56. South Africa Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 57. Saudi Arabia Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 58. Turkey Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 59. Argentina Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 60. UAE Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 61. Egypt Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 62. Chile Artificial Blood Substitute Market Size (2021-2032) & (US$ Million) Figure 63. Research Process Figure 64. Key Executives Interviewed

Scope & coverage.

Types
  • Perfluorocarbon-based Oxygen Carrier (PFBOC)
  • Hemoglobin-based Oxygen Carrier (HBOC)
Applications
  • Military
  • Civil
Companies covered
  • Aurum Biosciences Ltd.
  • HEMARINA SA
  • HbO2 Therapeutics
  • KaloCyte Inc.
  • SpheriTech Ltd.
  • NuvOx Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Artificial Blood Substitute Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Perfluorocarbon-based Oxygen Carrier (PFBOC)
  5. 1.2.3 Hemoglobin-based Oxygen Carrier (HBOC)
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Artificial Blood Substitute Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Military
  9. 1.3.3 Civil
  10. 1.4 Global Market Growth Prospects
  11. 1.5 Global Artificial Blood Substitute Growth Trends by Region
  12. 1.5.1 Global Artificial Blood Substitute Market Size by Region: 2021 VS 2025 VS 2032
  13. 1.5.2 Artificial Blood Substitute Market Size by Region (2021-2026)
  14. 1.5.3 Artificial Blood Substitute Market Size by Region (2027-2032)
  15. 1.6 Assumptions and Limitations
  16. 1.7 Study Goals and Objectives
  17. 1.8 Years Considered
2 Global Artificial Blood Substitute Market Dynamics
  1. 2.1 Artificial Blood Substitute Industry Trends
  2. 2.2 Artificial Blood Substitute Industry Drivers
  3. 2.3 Artificial Blood Substitute Industry Opportunities and Challenges
  4. 2.4 Artificial Blood Substitute Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Artificial Blood Substitute Revenue by Company (2021-2026)
  2. 3.2 Global Artificial Blood Substitute Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Artificial Blood Substitute Key Company Head office and Area Served
  4. 3.4 Global Artificial Blood Substitute Company, Product Type & Application
  5. 3.5 Global Artificial Blood Substitute Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Artificial Blood Substitute Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Artificial Blood Substitute Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Artificial Blood Substitute Tier 1, Tier 2, and Tier 3
4 Artificial Blood Substitute Market by Type
  1. 4.1 Global Artificial Blood Substitute Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Artificial Blood Substitute Market Size by Type (2021-2032)
  3. 4.3 Global Artificial Blood Substitute Market Size Share by Type (2021-2032)
5 Artificial Blood Substitute Market by Application
  1. 5.1 Global Artificial Blood Substitute Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Artificial Blood Substitute Market Size by Application (2021-2032)
  3. 5.3 Global Artificial Blood Substitute Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Aurum Biosciences Ltd.
  2. 6.1.1 Aurum Biosciences Ltd. Company Information
  3. 6.1.2 Aurum Biosciences Ltd. Business Overview
  4. 6.1.3 Aurum Biosciences Ltd. Artificial Blood Substitute Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Aurum Biosciences Ltd. Artificial Blood Substitute Product Portfolio
  6. 6.1.5 Aurum Biosciences Ltd. Recent Developments
  7. 6.2 HEMARINA SA
  8. 6.2.1 HEMARINA SA Company Information
  9. 6.2.2 HEMARINA SA Business Overview
  10. 6.2.3 HEMARINA SA Artificial Blood Substitute Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 HEMARINA SA Artificial Blood Substitute Product Portfolio
  12. 6.2.5 HEMARINA SA Recent Developments
  13. 6.3 HbO2 Therapeutics
  14. 6.3.1 HbO2 Therapeutics Company Information
  15. 6.3.2 HbO2 Therapeutics Business Overview
  16. 6.3.3 HbO2 Therapeutics Artificial Blood Substitute Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 HbO2 Therapeutics Artificial Blood Substitute Product Portfolio
  18. 6.3.5 HbO2 Therapeutics Recent Developments
  19. 6.4 KaloCyte Inc.
  20. 6.4.1 KaloCyte Inc. Company Information
  21. 6.4.2 KaloCyte Inc. Business Overview
  22. 6.4.3 KaloCyte Inc. Artificial Blood Substitute Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 KaloCyte Inc. Artificial Blood Substitute Product Portfolio
  24. 6.4.5 KaloCyte Inc. Recent Developments
  25. 6.5 SpheriTech Ltd.
  26. 6.5.1 SpheriTech Ltd. Company Information
  27. 6.5.2 SpheriTech Ltd. Business Overview
  28. 6.5.3 SpheriTech Ltd. Artificial Blood Substitute Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 SpheriTech Ltd. Artificial Blood Substitute Product Portfolio
  30. 6.5.5 SpheriTech Ltd. Recent Developments
  31. 6.6 NuvOx Pharma
  32. 6.6.1 NuvOx Pharma Company Information
  33. 6.6.2 NuvOx Pharma Business Overview
  34. 6.6.3 NuvOx Pharma Artificial Blood Substitute Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 NuvOx Pharma Artificial Blood Substitute Product Portfolio
  36. 6.6.5 NuvOx Pharma Recent Developments
7 North America
  1. 7.1 North America Artificial Blood Substitute Market Size (2021-2032)
  2. 7.2 North America Artificial Blood Substitute Market Size by Type
  3. 7.2.1 North America Artificial Blood Substitute Market Size by Type (2021-2026)
  4. 7.2.2 North America Artificial Blood Substitute Market Size by Type (2027-2032)
  5. 7.2.3 North America Artificial Blood Substitute Market Share by Type (2021-2032)
  6. 7.3 North America Artificial Blood Substitute Market Size by Application
  7. 7.3.1 North America Artificial Blood Substitute Market Size by Application (2021-2026)
  8. 7.3.2 North America Artificial Blood Substitute Market Size by Application (2027-2032)
  9. 7.3.3 North America Artificial Blood Substitute Market Share by Application (2021-2032)
  10. 7.4 North America Artificial Blood Substitute Market Size by Country
  11. 7.4.1 North America Artificial Blood Substitute Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Artificial Blood Substitute Market Size by Country (2021-2026)
  13. 7.4.3 North America Artificial Blood Substitute Market Size by Country (2027-2032)
  14. 7.4.4 North America Artificial Blood Substitute Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Artificial Blood Substitute Market Size (2021-2032)
  2. 8.2 Europe Artificial Blood Substitute Market Size by Type
  3. 8.2.1 Europe Artificial Blood Substitute Market Size by Type (2021-2026)
  4. 8.2.2 Europe Artificial Blood Substitute Market Size by Type (2027-2032)
  5. 8.2.3 Europe Artificial Blood Substitute Market Share by Type (2021-2032)
  6. 8.3 Europe Artificial Blood Substitute Market Size by Application
  7. 8.3.1 Europe Artificial Blood Substitute Market Size by Application (2021-2026)
  8. 8.3.2 Europe Artificial Blood Substitute Market Size by Application (2027-2032)
  9. 8.3.3 Europe Artificial Blood Substitute Market Share by Application (2021-2032)
  10. 8.4 Europe Artificial Blood Substitute Market Size by Country
  11. 8.4.1 Europe Artificial Blood Substitute Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Artificial Blood Substitute Market Size by Country (2021-2026)
  13. 8.4.3 Europe Artificial Blood Substitute Market Size by Country (2027-2032)
  14. 8.4.4 Europe Artificial Blood Substitute Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Artificial Blood Substitute Market Size (2021-2032)
  2. 9.2 China Artificial Blood Substitute Market Size by Type
  3. 9.2.1 China Artificial Blood Substitute Market Size by Type (2021-2026)
  4. 9.2.2 China Artificial Blood Substitute Market Size by Type (2027-2032)
  5. 9.2.3 China Artificial Blood Substitute Market Share by Type (2021-2032)
  6. 9.3 China Artificial Blood Substitute Market Size by Application
  7. 9.3.1 China Artificial Blood Substitute Market Size by Application (2021-2026)
  8. 9.3.2 China Artificial Blood Substitute Market Size by Application (2027-2032)
  9. 9.3.3 China Artificial Blood Substitute Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Artificial Blood Substitute Market Size (2021-2032)
  2. 10.2 Asia Artificial Blood Substitute Market Size by Type
  3. 10.2.1 Asia Artificial Blood Substitute Market Size by Type (2021-2026)
  4. 10.2.2 Asia Artificial Blood Substitute Market Size by Type (2027-2032)
  5. 10.2.3 Asia Artificial Blood Substitute Market Share by Type (2021-2032)
  6. 10.3 Asia Artificial Blood Substitute Market Size by Application
  7. 10.3.1 Asia Artificial Blood Substitute Market Size by Application (2021-2026)
  8. 10.3.2 Asia Artificial Blood Substitute Market Size by Application (2027-2032)
  9. 10.3.3 Asia Artificial Blood Substitute Market Share by Application (2021-2032)
  10. 10.4 Asia Artificial Blood Substitute Market Size by Country
  11. 10.4.1 Asia Artificial Blood Substitute Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Artificial Blood Substitute Market Size by Country (2021-2026)
  13. 10.4.3 Asia Artificial Blood Substitute Market Size by Country (2027-2032)
  14. 10.4.4 Asia Artificial Blood Substitute Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Artificial Blood Substitute Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Artificial Blood Substitute Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Artificial Blood Substitute Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Artificial Blood Substitute Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Artificial Blood Substitute Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Artificial Blood Substitute Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Artificial Blood Substitute Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Artificial Blood Substitute Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Artificial Blood Substitute Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Artificial Blood Substitute Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Artificial Blood Substitute Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Artificial Blood Substitute Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Artificial Blood Substitute Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Artificial Blood Substitute Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst